InvestorsHub Logo
Followers 7
Posts 578
Boards Moderated 0
Alias Born 08/29/2014

Re: None

Friday, 04/10/2015 1:15:11 PM

Friday, April 10, 2015 1:15:11 PM

Post# of 402957
Durata Therapeutics was bought out Nov 2014 for 675 million based on dalbavancin for ABSSI. Seems logical that an approved B for ABSSI is at least worth 675 million on a straight sell of this single indication. IMHO Who knows maybe Ehrlich takes 50 million upfront with the right to buy it at 750 million upon approval. Just thinking one of many possibilities.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News